Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...